DECA DURABOLIN INJ 100MG/ML DIN 00270687
Health Canada record
| Active ingredient(s) | NANDROLONE DECANOATE 100 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Human |
| ATC | A14AB01 NANDROLONE |
| Original market date | 31-Dec-1973 |
| Current status date | 26-Jul-2010 |
| Source | Health Canada DPD |
Establishment licence of the holder
Schering-Plough Mexico S.A. DE C.V. — licence , not currently licensed, last inspection rating C (2022-08-29).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NANDROLONE DECANOATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00022462 | DECA DURABOLIN INJ 50MG/ML | ORGANON CANADA LTD LTEE | Liquid | NANDROLONE DECANOATE 50 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 9982 | 2009-01-06 | New Drug Submission (NDS) | Manufacturer name change |
International API supply for NANDROLONE DECANOATE
1 active FDA Drug Master Files.
Request a quote for DECA DURABOLIN INJ 100MG/ML